Quantbot Technologies’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $117K | Buy |
+464
| New | +$99.8K | ﹤0.01% | 1422 |
|
|
2025
Q3 | – | Sell |
-14,619
| Closed | -$2.71M | – | 1694 |
|
|
2025
Q2 | $2.71M | Buy |
+14,619
| New | +$2.72M | 0.07% | 410 |
|
|
2025
Q1 | – | Sell |
-1,047
| Closed | -$186K | – | 1419 |
|
|
2024
Q4 | $186K | Buy |
1,047
+276
| +36% | +$50.7K | 0.01% | 1065 |
|
|
2024
Q3 | $152K | Buy |
+771
| New | +$144K | 0.01% | 1076 |
|
|
2024
Q1 | – | Sell |
-501
| Closed | -$77.6K | – | 1506 |
|
|
2023
Q4 | $77.6K | Sell |
501
-1,842
| -79% | -$269K | ﹤0.01% | 1246 |
|
|
2023
Q3 | $349K | Buy |
+2,343
| New | +$344K | 0.02% | 751 |
|
|
2023
Q2 | – | Sell |
-9,799
| Closed | -$1.56M | – | 1519 |
|
|
2023
Q1 | $1.56M | Buy |
9,799
+8,234
| +526% | +$1.26M | 0.11% | 269 |
|
|
2022
Q4 | $253K | Buy |
+1,565
| New | +$240K | 0.02% | 807 |
|
|
2021
Q4 | – | Sell |
-10,504
| Closed | -$1.13M | – | 1437 |
|
|
2021
Q3 | $1.13M | Sell |
10,504
-13,539
| -56% | -$1.55M | 0.08% | 351 |
|
|
2021
Q2 | $2.71M | Buy |
+24,043
| New | +$2.71M | 0.21% | 131 |
|
|
2021
Q1 | – | Sell |
-21,760
| Closed | -$2.33M | – | 1357 |
|
|
2020
Q4 | $2.33M | Buy |
21,760
+13,287
| +157% | +$1.28M | 0.24% | 118 |
|
|
2020
Q3 | $742K | Sell |
8,473
-13,156
| -61% | -$1.24M | 0.09% | 275 |
|
|
2020
Q2 | $2.12M | Buy |
21,629
+18,944
| +706% | +$1.67M | 0.28% | 111 |
|
|
2020
Q1 | $204K | Buy |
+2,685
| New | +$229K | 0.13% | 215 |
|
|
2019
Q3 | – | Sell |
-5,624
| Closed | -$408K | – | 1235 |
|
|
2019
Q2 | $408K | Sell |
5,624
-12,676
| -69% | -$996K | 0.04% | 424 |
|
|
2019
Q1 | $1.47M | Buy |
+18,300
| New | +$1.5M | 0.14% | 201 |
|
|
2018
Q4 | – | Sell |
-70,930
| Closed | -$6.71M | – | 986 |
|
|
2018
Q3 | $6.71M | Sell |
70,930
-11,219
| -14% | -$1.06M | 0.47% | 36 |
|
|
2018
Q2 | $7.61M | Buy |
82,149
+41,958
| +104% | +$4.1M | 0.52% | 22 |
|
|
2018
Q1 | $3.8M | Buy |
+40,191
| New | +$4.42M | 0.33% | 74 |
|
|
2017
Q2 | – | Sell |
-28,337
| Closed | -$1.85M | – | 1073 |
|
|
2017
Q1 | $1.85M | Buy |
+28,337
| New | +$1.78M | 0.19% | 129 |
|
|
2016
Q3 | – | Sell |
-26,640
| Closed | -$1.65M | – | 1044 |
|
|
2016
Q2 | $1.65M | Buy |
26,640
+22,040
| +479% | +$1.34M | 0.18% | 156 |
|
|
2016
Q1 | $262K | Buy |
+4,600
| New | +$256K | 0.04% | 460 |
|
|
2015
Q4 | – | Sell |
-72,321
| Closed | -$3.93M | – | 1039 |
|
|
2015
Q3 | $3.93M | Buy |
+72,321
| New | +$4.71M | 0.69% | 23 |
|
|
2015
Q1 | – | Sell |
-13,480
| Closed | -$882K | – | 1020 |
|
|
2014
Q4 | $882K | Buy |
+13,480
| New | +$850K | 0.28% | 80 |
|
|
2014
Q2 | – | Sell |
-27,522
| Closed | -$1.41M | – | 1124 |
|
|
2014
Q1 | $1.41M | Buy |
27,522
+5,591
| +25% | +$283K | 0.33% | 77 |
|
|
2013
Q4 | $1.16M | Buy |
+21,931
| New | +$1.08M | 0.57% | 34 |
|
|
2013
Q3 | – | Sell |
-40,534
| Closed | -$1.68M | – | 752 |
|
|
2013
Q2 | $1.68M | Buy |
+40,534
| New | +$1.77M | 0.88% | 23 |
|
Other funds holding ABBV
Quantbot Technologies's ABBV Position: Q2 2026 in Review
Quantbot Technologies opened a new position in AbbVie (ABBV) in Q2 2026: 464 shares worth $117K. The stake represents ﹤0.01% of the portfolio and ranks #1422 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in ABBV as recently as Q2 2025.
Quantbot Technologies first reported a position in ABBV in Q2 2013 and has held it in 27 quarters since. The position peaked at $7.61M in Q2 2018. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Quantbot Technologies held 464 shares of AbbVie worth $117K as of Q2 2026.
- AbbVie was a new Quantbot Technologies position in Q2 2026.
- AbbVie made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1422 holding.
- Quantbot Technologies first reported a position in AbbVie in Q2 2013 and has held it in 27 quarters since.
- Quantbot Technologies's AbbVie position peaked at $7.61M in Q2 2018.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.